Antiestrogenicity of clarified slurry oil and two crude oils in a human breast-cancer cell assay

被引:22
作者
Arcaro, KF
Gierthy, JF
Mackerer, CR
机构
[1] SUNY Albany, Sch Publ Hlth, Dept Environm Hlth & Toxicol, Rensselaer, NY 12144 USA
[2] New York State Dept Hlth, Wadsworth Ctr Labs & Res, Albany, NY 12201 USA
[3] Mobil Business Resources Corp, Paulsboro, NJ USA
来源
JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A-CURRENT ISSUES | 2001年 / 62卷 / 07期
关键词
D O I
10.1080/152873901300007815
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Exposure to crude oil and certain petroleum products can be a serious health hazard. Clarified slurry oil (CSO) is a complex mixture of hydrocarbons derived from the processing of crude oil, and is a known systemic and developmental toxicant. mutagen, and carcinogen. In the present study, CSO and two crude oils, Belridge heavy crude oil (BHCO) and Lost Hills light crude oil (LHLCO), were examined for their estrogenic and antiestrogenic properties in a human breast-cancer cell (MCF-7) assay. The MCF-7 focus assay is based on postconfluent cell growth and tissue restructuring, measured as the postconfluent development of multicellular nodules or loci. The mutagenicity indices of BHCO and LHLCO also were determined in a modified Ames Salmonella assay. Oil samples were prepared in dimethyl sulfoxide, resulting in extraction of virtually all of the aromatic compounds including the sulfur- and nitrogen-substituted three- to seven-ring polycyclic aromatic compounds comprising 62.2% of the CSO, 9% of the BHCO, and 2% of the LHLCO by total weight. None of the three samples was estrogenic in the MCF-7 locus assay. In contrast, all of the samples were antiestrogenic; that is, they inhibited the development of foci induced by 1 nM 17 beta -estradiol (E-2). The potencies of the oil samples for both antiestrogenicity and mutagenicity were correlated with the percent of polycyclic aromatic compounds they contained. Two potential mechanisms for the observed antiestrogenicity were examined. Radiometric analysis of the catabolism of [H-3]E-2 in MCF-7 cell cultures demonstrated that all three samples increased catabolism of E-2. Results from a whole-cell estrogen-receptor (ER) binding assay suggested that metabolites of compounds in the oil samples might have competed with [H-3]E-2 for ER in the MCF-7 cultures. Thus the antiestrogenicity ui the oil samples may occur through at least two mechanisms, increased catabolism of E-2 and antagonistic binding to ER.
引用
收藏
页码:505 / 521
页数:17
相关论文
共 45 条
[1]   METHODS FOR DETECTING CARCINOGENS AND MUTAGENS WITH SALMONELLA-MAMMALIAN-MICROSOME MUTAGENICITY TEST [J].
AMES, BN ;
MCCANN, J ;
YAMASAKI, E .
MUTATION RESEARCH, 1975, 31 (06) :347-363
[2]   Antiestrogenicity of environmental polycyclic aromatic hydrocarbons in human breast cancer cells [J].
Arcaro, KF ;
O'Keefe, PW ;
Yang, Y ;
Clayton, W ;
Gierthy, JF .
TOXICOLOGY, 1999, 133 (2-3) :115-127
[3]  
Arcaro KF, 1999, J CELL BIOCHEM, V72, P94, DOI 10.1002/(SICI)1097-4644(19990101)72:1<94::AID-JCB10>3.3.CO
[4]  
2-P
[5]   Benzo[k]fluoranthene enhancement and suppression of 17β-estradiol catabolism in MCF-7 breast cancer cells [J].
Arcaro, KF ;
Yang, Y ;
Gierthy, JF .
JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A-CURRENT ISSUES, 1999, 58 (07) :413-426
[6]   PREDICTING CARCINOGENICITY OF PETROLEUM DISTILLATION FRACTIONS USING A MODIFIED SALMONELLA MUTAGENICITY ASSAY [J].
BLACKBURN, GR ;
DEITCH, RA ;
SCHREINER, CA ;
MACKERER, CR .
CELL BIOLOGY AND TOXICOLOGY, 1986, 2 (01) :63-84
[7]   ESTIMATION OF THE DERMAL CARCINOGENIC ACTIVITY OF PETROLEUM FRACTIONS USING A MODIFIED AMES ASSAY [J].
BLACKBURN, GR ;
DEITCH, RA ;
SCHREINER, CA ;
MEHLMAN, MA ;
MACKERER, CR .
CELL BIOLOGY AND TOXICOLOGY, 1984, 1 (01) :67-80
[8]   Evidence of estrogen- and TCDD-like activities in crude and fractionated extracts of PM10 air particulate material using in vitro gene expression assays [J].
Clemons, JH ;
Allan, LM ;
Marvin, CH ;
Wu, Z ;
McCarry, BE ;
Bryant, DW ;
Zacharewski, TR .
ENVIRONMENTAL SCIENCE & TECHNOLOGY, 1998, 32 (12) :1853-1860
[9]  
CRUICKSHANK CND, 1952, BRIT J IND MED, V9, P74
[10]  
CRUZAN G, 1986, Toxicology and Industrial Health, V2, P429